debating the risks, benefits of a controversial alzheimer's drug
Published 3 years ago • 4.2K plays • Length 6:01
Download video MP4
Download video MP3
Similar videos
-
6:00
why the fda approved a controversial alzheimer's drug
-
29:47
the alzheimer’s treatment controversy: implications of accelerated drug approvals
-
3:38
alzheimer's drug hailed as breakthrough, but may have side effects
-
3:43
hope and anxiety surround new alzheimer’s drug lecanemab
-
5:32
experimental alzheimer's drug may slow progression, but with significant side effects, study shows
-
18:32
which foods have gone relatively unscathed by inflation? | about that
-
11:41
4 types of exercise to reverse alzheimer’s & dementia
-
11:09
the real cause of alzheimer's is not amyloid plaque in the brain
-
3:31
fda approves controversial biogen alzheimer's drug | dw news
-
5:49
how new alzheimer's drug leqembi works, risks and who might benefit
-
5:31
treatment option that slows the progression of alzheimer’s disease
-
45:58
cbc news: the national | stranded in a snowstorm, alzheimer's drug, landlords vs. renters
-
3:31
that pricey new alzheimer's drug? still not great
-
1:51
new alzheimer's drug shows promise in slowing disease
-
8:39
what is the controversy over aducanumab/aduhelm for alzheimer's?
-
6:38
new drugs show small but positive results in fight against alzheimer’s
-
4:42
us fda approves 1st new alzheimer’s drug in nearly 20 years
-
2:19
in controversial decision, fda approves first new alzheimer's disease drug in nearly 20 years
-
2:12
mount sinai decides against using controversial alzheimer's drug
-
24:36
“aduhelm, is this medication changing the game for alzheimer’s disease?” gregory cooper, m.d., ph.d.
-
3:43
marwan sabbagh, md: outlook of aducanumab in alzheimer disease
-
58:38
implications of aducanumab, the new alzheimer's drug with gil rabinovici and rita redberg
Clip.africa.com - Privacy-policy